EA201100910A1 - Лечение воспалительных заболеваний кишечника бета-дефенсинами млекопитающих - Google Patents

Лечение воспалительных заболеваний кишечника бета-дефенсинами млекопитающих

Info

Publication number
EA201100910A1
EA201100910A1 EA201100910A EA201100910A EA201100910A1 EA 201100910 A1 EA201100910 A1 EA 201100910A1 EA 201100910 A EA201100910 A EA 201100910A EA 201100910 A EA201100910 A EA 201100910A EA 201100910 A1 EA201100910 A1 EA 201100910A1
Authority
EA
Eurasian Patent Office
Prior art keywords
treatment
beta
defensins
intestine
mammals
Prior art date
Application number
EA201100910A
Other languages
English (en)
Inventor
Таня Мария Росенкилле Кьер
Томас Крусе
Пер Хольсе Мюгинн
Каролине Сидельманн Бринч
Серен Кьерульфф
Биргитте Андерсен
Original Assignee
Новозимс Эдениум Байотек А/С
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41530820&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA201100910(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Новозимс Эдениум Байотек А/С filed Critical Новозимс Эдениум Байотек А/С
Publication of EA201100910A1 publication Critical patent/EA201100910A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4723—Cationic antimicrobial peptides, e.g. defensins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A61K38/1729—Cationic antimicrobial peptides, e.g. defensins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Изобретение относится к применению бета-дефенсина млекопитающего для производства лекарственного средства для парентерального введения, например фармацевтической композиции, для лечения воспалительного заболевания кишечника.
EA201100910A 2008-07-18 2009-07-17 Лечение воспалительных заболеваний кишечника бета-дефенсинами млекопитающих EA201100910A1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP08160761 2008-07-18
EP08162486 2008-08-15
EP08163614 2008-09-03

Publications (1)

Publication Number Publication Date
EA201100910A1 true EA201100910A1 (ru) 2012-05-30

Family

ID=41530820

Family Applications (2)

Application Number Title Priority Date Filing Date
EA201100910A EA201100910A1 (ru) 2008-07-18 2009-07-17 Лечение воспалительных заболеваний кишечника бета-дефенсинами млекопитающих
EA201170219A EA201170219A1 (ru) 2008-07-18 2009-07-17 Лечение воспалительных заболеваний кишечника бета-дефенсинами млекопитающих

Family Applications After (1)

Application Number Title Priority Date Filing Date
EA201170219A EA201170219A1 (ru) 2008-07-18 2009-07-17 Лечение воспалительных заболеваний кишечника бета-дефенсинами млекопитающих

Country Status (20)

Country Link
US (4) US8232242B2 (ru)
EP (2) EP2320930A2 (ru)
JP (2) JP2011528333A (ru)
KR (1) KR20110092325A (ru)
CN (2) CN102247591A (ru)
AP (2) AP2011005755A0 (ru)
AR (2) AR072032A1 (ru)
AU (1) AU2009272681A1 (ru)
BR (2) BRPI0924481A2 (ru)
CA (2) CA2750727A1 (ru)
CL (1) CL2011000099A1 (ru)
EA (2) EA201100910A1 (ru)
IL (2) IL210715A0 (ru)
MX (1) MX2011000568A (ru)
NZ (2) NZ593653A (ru)
PH (1) PH12012501542A1 (ru)
SG (1) SG172709A1 (ru)
TW (2) TW201138810A (ru)
WO (1) WO2010007166A2 (ru)
ZA (1) ZA201100461B (ru)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ590469A (en) * 2008-07-18 2012-08-31 Novozymes Adenium Biotech As Treatment of rheumatoid arthritis with human beta defensins (1-4)
EA201170218A1 (ru) * 2008-07-18 2011-08-30 Новозимс Эдениум Байотек А/С Лечение воспалительных заболеваний бета-дефенсинами млекопитающих
NZ593653A (en) 2008-07-18 2012-09-28 Novozymes Adenium Biotech As Treatment of inflammatory bowel diseases with mammal beta defensins
KR101249702B1 (ko) * 2010-06-16 2013-04-05 주식회사 나이벡 항균 또는 항염증 활성을 가지는 펩타이드 및 이를 유효성분으로 함유하는 약제학적 조성물
ES2712098T3 (es) 2011-04-15 2019-05-09 Marine Polymer Tech Inc Tratamiento de infecciones por VHS con nanofibras de poli-N-acetilglucosamina
ES2637286T3 (es) 2011-07-08 2017-10-11 Defensin Therapeutics Aps Tratamiento oral de la enfermedad inflamatoria intestinal
WO2013026794A1 (en) 2011-08-19 2013-02-28 Novozymes Novel immunomodulatory peptide
US10257564B2 (en) * 2013-01-24 2019-04-09 Saturn Licensing Llc Distributed non-real-time content
CN104628864B (zh) * 2013-11-14 2020-04-10 中国医学科学院医药生物技术研究所 一种抗肿瘤融合蛋白EL-defensin、其编码基因和用途
SG11201809086YA (en) 2016-04-29 2018-11-29 Defensin Therapeutics Aps Treatment of liver, biliary tract and pancreatic disorders
CN110290799A (zh) 2016-12-13 2019-09-27 防御素治疗学公司 用于治疗肺部炎性病症的方法
CA3082288A1 (en) * 2017-11-10 2019-05-16 Defensin Therapeutics Aps Maturation of mucosal defense and gut/lung function in the preterm infant
JP7423523B2 (ja) 2017-11-24 2024-01-29 ディフェンシン セラピューティクス エーピーエス ディフェンシンによる移植片対宿主病の予防と治療
KR102244161B1 (ko) * 2018-08-31 2021-04-26 주식회사 나이벡 다중의 질환 바이오마커의 기능 및 발현을 억제하는 펩타이드의 신규한 용도
CN113684162B (zh) * 2021-06-03 2024-02-27 江南大学 一种表达小鼠防御素mBD14基因的重组植物乳杆菌及其应用

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
IL99552A0 (en) 1990-09-28 1992-08-18 Ixsys Inc Compositions containing procaryotic cells,a kit for the preparation of vectors useful for the coexpression of two or more dna sequences and methods for the use thereof
DE4343591A1 (de) 1993-12-21 1995-06-22 Evotec Biosystems Gmbh Verfahren zum evolutiven Design und Synthese funktionaler Polymere auf der Basis von Formenelementen und Formencodes
US5605793A (en) 1994-02-17 1997-02-25 Affymax Technologies N.V. Methods for in vitro recombination
US6576755B1 (en) * 1997-09-10 2003-06-10 Zymogenetics, Inc. Beta-defensins
DE19957043A1 (de) * 1999-11-26 2001-06-07 Forssmann Wolf Georg Neue Defensine
US7338936B2 (en) * 2000-11-28 2008-03-04 House Ear Institute Use of antimicrobial proteins and peptides for the treatment of otitis media and paranasal sinusitis
US20080194481A1 (en) * 2001-12-21 2008-08-14 Human Genome Sciences, Inc. Albumin Fusion Proteins
FR2841556B1 (fr) 2002-07-01 2007-07-20 Centre Nat Rech Scient Peptides ayant des proprietes antimicrobiennes et les compositions les contenant notamment pour la conservation des aliments
KR20050089827A (ko) * 2002-12-19 2005-09-08 이츠차크 힐만 항균성 펩티드 억제물을 통한 질환 치료
US20070207209A1 (en) 2004-08-27 2007-09-06 Murphy Christopher J Trophic factor combinations for nervous system treatment
GB0514482D0 (en) * 2005-07-14 2005-08-17 Ares Trading Sa Protein
WO2007081486A2 (en) 2005-12-15 2007-07-19 Ventria Bioscience Oral administration of defensins to treat intestinal diseases
WO2007087557A2 (en) 2006-01-24 2007-08-02 University Of Maryland Biotechnology Institute Surface-layer protein coated microspheres and uses thereof
WO2009043507A2 (en) * 2007-09-11 2009-04-09 Mondobiotech Laboratories Ag Use of a peptide as a therapeutic agent
NZ593653A (en) 2008-07-18 2012-09-28 Novozymes Adenium Biotech As Treatment of inflammatory bowel diseases with mammal beta defensins
NZ590469A (en) 2008-07-18 2012-08-31 Novozymes Adenium Biotech As Treatment of rheumatoid arthritis with human beta defensins (1-4)
EA201170218A1 (ru) 2008-07-18 2011-08-30 Новозимс Эдениум Байотек А/С Лечение воспалительных заболеваний бета-дефенсинами млекопитающих
ES2637286T3 (es) 2011-07-08 2017-10-11 Defensin Therapeutics Aps Tratamiento oral de la enfermedad inflamatoria intestinal
WO2013026794A1 (en) 2011-08-19 2013-02-28 Novozymes Novel immunomodulatory peptide

Also Published As

Publication number Publication date
AP2011005538A0 (en) 2011-02-28
BRPI0924481A2 (pt) 2015-08-11
SG172709A1 (en) 2011-07-28
US20140135258A1 (en) 2014-05-15
JP2011225596A (ja) 2011-11-10
CA2730789A1 (en) 2010-01-21
WO2010007166A3 (en) 2010-06-03
US8802621B2 (en) 2014-08-12
ZA201100461B (en) 2014-03-26
IL213680A0 (en) 2011-07-31
PH12012501542A1 (en) 2015-11-09
EP2320930A2 (en) 2011-05-18
WO2010007166A2 (en) 2010-01-21
AR072032A1 (es) 2010-07-28
IL210715A0 (en) 2011-03-31
AR081948A2 (es) 2012-10-31
NZ590468A (en) 2012-06-29
CL2011000099A1 (es) 2011-10-07
MX2011000568A (es) 2011-02-23
EP2399600A1 (en) 2011-12-28
CN102247591A (zh) 2011-11-23
JP2011528333A (ja) 2011-11-17
CA2750727A1 (en) 2010-01-21
EA201170219A1 (ru) 2011-08-30
US8232242B2 (en) 2012-07-31
BRPI0915973A2 (pt) 2013-05-07
US20100016230A1 (en) 2010-01-21
AU2009272681A1 (en) 2010-01-21
AP2011005755A0 (en) 2011-06-30
US20110251139A1 (en) 2011-10-13
US20120309678A1 (en) 2012-12-06
TW201004640A (en) 2010-02-01
NZ593653A (en) 2012-09-28
CN102159233A (zh) 2011-08-17
US9279010B2 (en) 2016-03-08
KR20110092325A (ko) 2011-08-17
TW201138810A (en) 2011-11-16

Similar Documents

Publication Publication Date Title
EA201100910A1 (ru) Лечение воспалительных заболеваний кишечника бета-дефенсинами млекопитающих
BR112012016853A2 (pt) "composições farmacêuticas para administração oral de peptídeos de insulina".
EA031157B9 (ru) Вводимая перорально кортикостероидная композиция
BR112012011478A2 (pt) composições fosfolipídicas terapêuticas concentradas.
CU24117B1 (es) Derivados de la piridina de tieno (2,3-b) como inhibidores virales de la réplica
CO6680687A2 (es) Inmunoglobinas con dominio variable dual capaces de unirse a il 1 beta e il-17, composiciones farmaceúticas y conjugados de proteína de unión de las mismas
GT200900095A (es) Dihidropirazolonas sustituidas para el tratamiento de enfermedades cardiovasculares y hermatologicas.
UA96441C2 (ru) Фармацевтическая композиция, которая содержит аналог тиазолидиндиона митоглитазон, для лечения заболеваний, опосредованных метаболическим воспалением
CY1111454T1 (el) Παραγωγα φαινυλο-πυραζολιου ως συνδετες υποδοχεα μη στεροειδων γλυκοκορτικοειδων
CR20110255A (es) Nuevos compuestos 578
CL2009000402A1 (es) Compuestos derivados de 2-amino-acetamida sustituida; composicion farmaceutica; utiles en el tratamiento de enfermedades pulmonares, enfermedad reumatica, enfermedad autoinmune, entre otras.
WO2013007596A3 (en) Oral treatment of inflammatory bowel disease
BR112012002265B8 (pt) composições farmacêuticas para o tratamento de câncer e outras doenças ou distúrbios
PL2081910T3 (pl) Nowe związki
EA201001781A1 (ru) Применение гликозаминогликанов для перорального введения и композиции гликозаминогликанов
GEP20135832B (en) Benzothiazines derivatives, preparation thereof, and their application as drugs
BR112013026680A2 (pt) composto, método de tratamento de uma doença inflamatória e composição farmacêutica
EA200970849A1 (ru) Трициклические производные изохинолина для лечения ожирения
EA201491651A1 (ru) Новые соединения для лечения дислипидемии и родственных заболеваний
CL2010001577A1 (es) Uso de nifurtimox para preparar un medicamento util en el tratamiento de enfermedades causadas por giardias.
BR112014018226A8 (pt) Derivados de pirimidooxazocina como inibidores de mtor
FR2953723B1 (fr) Composition pharmaceutique destinee au traitement des pathologies orthopediques
CY1121280T1 (el) Χρηση της θυαζολοπυριμιδινονης για τη θεραπεια της φλεγμονωδους νοσου του εντερου
FR2960780B1 (fr) Medicament pour le traitement de la maladie de parkinson
CY1116514T1 (el) Αναστολεις toy nf-kb